吉華集團(603980.SH):子公司擬出售部分資產
格隆匯5月13日丨吉華集團(603980.SH)公佈,公司全資子公司江蘇吉華化工有限公司(簡稱“江蘇吉華”)與濱海縣沿海投資發展有限公司(簡稱“沿海投資”)於2025年5月13日簽署《資產收購協議》,沿海投資擬以現金8,500.00萬元收購江蘇吉華登記在《蘇2018濱海縣不動產權第0000604號》上的300,030.60平方米土地使用權和30,182.06平方米房屋所有權,以及在上述土地上的其他建築物、構築物及附屬設施。截至2024年12月31日,標的資產經審計的賬面淨值為7,345.71萬元(不含税),本次交易價格與賬面淨值溢價1,154.29萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.